Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3031% below fair value
$28.87+0.27 (+0.94%)
Close on Nov 12, 2026Market cap $1.23BP/E 13.1Yield –
Amphastar Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Amphastar Pharmaceuticals's price to sales ratio was 1.7× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.2× to 5.6×, with a median of 3.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | −0.0 |
| 2025 | Dec 31, 2025 | 1.7× | −0.8 |
| 2024 | Dec 31, 2024 | 2.5× | −2.4 |
| 2023 | Dec 29, 2023 | 4.9× | +2.1 |
| 2022 | Dec 30, 2022 | 2.8× | +0.1 |
| 2021 | Dec 31, 2021 | 2.7× | −0.1 |
| 2020 | Dec 31, 2020 | 2.8× | +0.1 |
| 2019 | Dec 31, 2019 | 2.8× | −0.7 |
| 2018 | Dec 31, 2018 | 3.5× | −0.2 |
| 2017 | Dec 29, 2017 | 3.6× | +0.5 |
| 2016 | Dec 30, 2016 | 3.2× | +0.4 |
| 2015 | Dec 31, 2015 | 2.8× | +0.3 |
| 2014 | Dec 31, 2014 | 2.5× | – |
See a number that looks wrong?